Cargando…
Overexpressed Galectin-3 in Pancreatic Cancer Induces Cell Proliferation and Invasion by Binding Ras and Activating Ras Signaling
Pancreatic cancer (PDAC) is a lethal disease with a five-year survival of 3–5%. Mutations in K-Ras are found in nearly all cases, but K-Ras mutations alone are not sufficient for the development of PDAC. Additional factors contribute to activation of Ras signaling and lead to tumor formation. Galect...
Autores principales: | Song, Shumei, Ji, Baoan, Ramachandran, Vijaya, Wang, Huamin, Hafley, Margarete, Logsdon, Craig, Bresalier, Robert S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416861/ https://www.ncbi.nlm.nih.gov/pubmed/22900040 http://dx.doi.org/10.1371/journal.pone.0042699 |
Ejemplares similares
-
The Significance of Ras Activity in Pancreatic Cancer Initiation
por: Logsdon, Craig D., et al.
Publicado: (2016) -
Galectin-8 binds to the Farnesylated C-terminus of K-Ras4B and Modifies Ras/ERK Signaling and Migration in Pancreatic and Lung Carcinoma Cells
por: Meinohl, Christopher, et al.
Publicado: (2019) -
Inhibition of malignant thyroid carcinoma cell proliferation by Ras and galectin-3 inhibitors
por: Menachem, A, et al.
Publicado: (2015) -
Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics
por: Ilmer, Matthias, et al.
Publicado: (2016) -
Ras in epidermal proliferation
por: Drosten, Matthias, et al.
Publicado: (2014)